🇺🇸 FDA
Pipeline program

AO-128

AO-128/OCT-910

Approved small_molecule completed

Quick answer

AO-128 for Impaired Glucose Tolerance (IGT) is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Impaired Glucose Tolerance (IGT)
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials